MedTrace Logo

Development of a Cough Control Questionnaire (CCQ)

NCT06918756 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-04-09

No results posted yet for this study

Summary

Chronic cough (\>8 weeks in duration) affects 5-12% of the global population, and is associated with considerable health status impairment and comorbidities. Currently, there are validated severity and impact outcome measures whilst objective measures with cough frequency monitoring is not available in routine clinical practice. Unlike other chronic respiratory diseases, namely asthma, there are no validated dedicated tools to assess the control of cough as a disease.

This study aims to develop a validated patient-focused tool to assess the control of cough, which may be useful to evaluate the benefit and value of treatments in both clinical and research settings.

Conditions

Interventions

OTHER

Questionnaires

Completion of new questionnaire in addition to other patient reported outcome measures that measure cough severity and cough-related quality of life.

OTHER

Focus group interviews

Semi-structured focus group interviews for patients with refractory chronic cough

OTHER

Objective cough measures

Cough monitoring and cough sensitivity testing.

Sponsors & Collaborators

  • King's College Hospital NHS Trust

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2031-09-01
Completion
2031-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06918756 on ClinicalTrials.gov